Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Redx Pharma is a drug discovery and development company.
Home Biosciences is a European venture builder dedicated to biotech.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Bambusa Therapeutics operates as biotechnology company.
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Redmile Group has invested in 105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Redmile Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 19 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post-IPO Equity round. Redmile Group's total known invested capital is $12.6B.
Redmile Group's average investment size is $119.9M across its portfolio of 105 companies.
Recent Redmile Group portfolio additions include Boundless Bio, Orbital Therapeutics, MedAvail, Pliant Therapeutics, Escient Pharmaceuticals. These companies were founded in 2020 or later.